Conditions: Advanced and Metastatic Silent Neuro-Endocrine Tumors Carcinoma Neuroendocrine Non Functioning Neuroendocrine Tumors (NETs) Non Syndromic Neuroendocrine Tumors Carcinoids Non Functioning
Keywords: Neuroendocrine tumors non functioning neuroendocrine tumors Non syndromic neuroendocrine tumors carcinoids non-functioning carcinoids adults everolimus NET RAMSETE CRAD001 non-functioning neuroendocrine tumors carcinoids
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 73
Healthy volunteers: no

Brief summary:
To evaluate the preliminary efficacy and safety of RAD001 as monotherapy for first-line treatment of patients with metastatic papillary carcinoma of the kidney.

Detailed description:

Arms:
arm 1: Everolimus

Interventions: intervention 1: Everolimus
Intervention descriptions: intervention 1: Everolimus 5 mg tablets were supplied in blister packs

Protocol document: